FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103294838> ?p ?o ?g. }

• W2103294838 endingPage "83" @default.
• W2103294838 startingPage "77" @default.
• W2103294838 abstract "Abstract: We studied glycocalicin (GC), expressed as plasma GC concentration and as GC index (ratio to platelet count), in 129 thrombocytopenic patients (platelet count <100×109/1) and 60 sex- and age-matched controls. Seventy-two patients had idiopathic immune thrombocytopenia, 32 secondary immune thrombocytopenia, 8 microangiopathic thrombocytopenia and 17 thrombocytopenia secondary to bone marrow aplasia. Patients with immune thrombocytopenia (ITP) were also subclassified, according to their clinical behaviour, as having active disease or being in spontaneous or therapy-induced partial remission. A significant correlation was found between glycocalicin levels and platelet count both in normals and in patients with bone marrow aplasia (r = 0.75). ITP patients showed a GC index significantly higher than controls (6.02±7.87 vs. 0.9±0.2, p<0.001). When ITP patients with similar platelet count (30–50×109/l) were studied, the mean level of GC and the GC index were significantly higher in those patients with active disease than in those in remission (0.97±0.38 vs. 0.58±0.17 μg/ml, p<0.05; 6.41±2.64 vs. 3.44±0.94, p<0.05, respectively). A longitudinal study performed in 10 patients with different subtypes of ITP suggested a positive correlation between GC index and the activity of the disease. The GC value and GC index were significantly higher in patients with microangiopathic thrombocytopenia than in controls (1.44±0.73 vs. 0.8±0.16 μg/ml, p<0.01; and 18.77±22.23 vs. 0.9±0.2, p<0.001, respectively). The GC value was significantly lower in bone marrow failure (0.15±0.04 μg/ml, p<0.01) compared to controls, while no difference was observed in the GC index. Our data confirm that the GC index is helpful in differentiating thrombocytopenia due to increased platelet destruction from the one due to impaired production. In addition, the assay has been proven useful in the differential diagnosis of different ITP subtypes and their follow-up." @default.
• W2103294838 created "2016-06-24" @default.
• W2103294838 creator A5003983960 @default.
• W2103294838 creator A5010426308 @default.
• W2103294838 creator A5046215401 @default.
• W2103294838 creator A5046561459 @default.
• W2103294838 creator A5050928849 @default.
• W2103294838 creator A5081539276 @default.
• W2103294838 date "2009-04-24" @default.
• W2103294838 modified "2023-09-27" @default.
• W2103294838 title "Glycocalicin in the diagnosis and management of immune thrombocytopenia" @default.
• W2103294838 cites W191818889 @default.
• W2103294838 cites W193961006 @default.
• W2103294838 cites W1982788708 @default.
• W2103294838 cites W1987281329 @default.
• W2103294838 cites W1995392078 @default.
• W2103294838 cites W2016854507 @default.
• W2103294838 cites W2071485229 @default.
• W2103294838 cites W2080664315 @default.
• W2103294838 cites W2142166517 @default.
• W2103294838 cites W2170761769 @default.
• W2103294838 cites W2319133769 @default.
• W2103294838 cites W27185196 @default.
• W2103294838 cites W4298380376 @default.
• W2103294838 cites W2084235917 @default.
• W2103294838 doi "https://doi.org/10.1111/j.1600-0609.1998.tb01065.x" @default.
• W2103294838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9714518" @default.
• W2103294838 hasPublicationYear "2009" @default.
• W2103294838 type Work @default.
• W2103294838 sameAs 2103294838 @default.
• W2103294838 citedByCount "6" @default.
• W2103294838 countsByYear W21032948382013 @default.
• W2103294838 countsByYear W21032948382016 @default.
• W2103294838 countsByYear W21032948382019 @default.
• W2103294838 crossrefType "journal-article" @default.
• W2103294838 hasAuthorship W2103294838A5003983960 @default.
• W2103294838 hasAuthorship W2103294838A5010426308 @default.
• W2103294838 hasAuthorship W2103294838A5046215401 @default.
• W2103294838 hasAuthorship W2103294838A5046561459 @default.
• W2103294838 hasAuthorship W2103294838A5050928849 @default.
• W2103294838 hasAuthorship W2103294838A5081539276 @default.
• W2103294838 hasConcept C126322002 @default.
• W2103294838 hasConcept C2778368355 @default.
• W2103294838 hasConcept C2993327898 @default.
• W2103294838 hasConcept C71924100 @default.
• W2103294838 hasConcept C89560881 @default.
• W2103294838 hasConcept C90924648 @default.
• W2103294838 hasConceptScore W2103294838C126322002 @default.
• W2103294838 hasConceptScore W2103294838C2778368355 @default.
• W2103294838 hasConceptScore W2103294838C2993327898 @default.
• W2103294838 hasConceptScore W2103294838C71924100 @default.
• W2103294838 hasConceptScore W2103294838C89560881 @default.
• W2103294838 hasConceptScore W2103294838C90924648 @default.
• W2103294838 hasIssue "2" @default.
• W2103294838 hasLocation W21032948381 @default.
• W2103294838 hasLocation W21032948382 @default.
• W2103294838 hasOpenAccess W2103294838 @default.
• W2103294838 hasPrimaryLocation W21032948381 @default.
• W2103294838 hasRelatedWork W2067131909 @default.
• W2103294838 hasRelatedWork W2103294838 @default.
• W2103294838 hasRelatedWork W2132924830 @default.
• W2103294838 hasRelatedWork W2325783479 @default.
• W2103294838 hasRelatedWork W2346820651 @default.
• W2103294838 hasRelatedWork W2396224172 @default.
• W2103294838 hasRelatedWork W3007215547 @default.
• W2103294838 hasRelatedWork W3201556146 @default.
• W2103294838 hasRelatedWork W4206105703 @default.
• W2103294838 hasRelatedWork W4308821260 @default.
• W2103294838 hasVolume "61" @default.
• W2103294838 isParatext "false" @default.
• W2103294838 isRetracted "false" @default.
• W2103294838 magId "2103294838" @default.
• W2103294838 workType "article" @default.